Vaccinating patients with autologous tumor

Journal of Clinical Oncology

Volumn 20, Issue 20, 2002, Pages 4139-4140

  Chapman, Paul B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CANCER VACCINE; HEAT SHOCK PROTEIN; HLA A ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; CANCER PATIENT; DRUG RESPONSE; EDITORIAL; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; VACCINATION;

EID: 0037108695     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.20.4139     Document Type: Editorial

References (8)

1. Southam CM: Applications of immunology to clinical cancer: Past attempts and future possibilities. Cancer Res 21:1302-1316, 1961
2. Belli F, Testori A, Rivoltini L, et al: Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings. J Clin Oncol 20:4169-4180, 2002
3. Mitchell MS. Von Eschen KB: Phase III trial of Melacine melanoma theraccine versus combination chemotherapy in the treatment of stage IV melanoma. Proc Am Soc Clin Oncol 16:494a, 1997 (abstr 1778)
4. Hsueh EC, Nathanson L, Foshag LJ, et al: Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases. Cancer 85:2160-2169, 1999
5. Berd D, Maquire H, McCue P, et al: Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunological results in 64 patients. J Clin Oncol 8:1858-1867. 1990
6. Berd D: Autologous, hapten-modified vaccine as a treatment for human cancers. Vaccine 19:2565-2570, 2001
7. Soiffer R, Lynch T, Mihm M, et al: Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocytemacrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A 95:13141-13146, 1998
8. Kageshita T, Wang Z, Calorini L, et al: Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res 53:3349-3354, 1993